CD274 and neoplasm: Accumulating evidence has confirmed abnormalities in the tumor microenvironment (TME) were correlated with the efficacy of PD-1/PD-L1 blockade and the angiogenic factors could contribute to the immunosuppression in the TME by inducing vascular abnormalities, suppressing antigen presentation and immune effector cells (28–31).